Loading...
The therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis
BACKGROUND: Somatostatin analog therapies showed great potential for patients suffering advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC ((177)Lu-octreotate/octreotide) peptide receptor radionuclide therapy (PRRT) in advance...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7478707/ https://ncbi.nlm.nih.gov/pubmed/32150065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019304 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|